Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Neonc Technologies (NTHI) Competitors

Neonc Technologies logo
$5.34 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$5.38 +0.04 (+0.84%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NTHI vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Neonc Technologies stock or one of its competitors? MarketBeat compares Neonc Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Neonc Technologies include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Neonc Technologies compare to Ainos?

Ainos (NASDAQ:AIMDW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, Neonc Technologies had 7 more articles in the media than Ainos. MarketBeat recorded 7 mentions for Neonc Technologies and 0 mentions for Ainos. Neonc Technologies' average media sentiment score of 0.22 beat Ainos' score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Ainos Neutral
Neonc Technologies Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Neonc Technologies N/A N/A N/A

Neonc Technologies has a consensus target price of $16.00, suggesting a potential upside of 199.63%. Given Neonc Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Neonc Technologies is more favorable than Ainos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ainos
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Neonc TechnologiesN/AN/AN/AN/AN/A

Summary

Neonc Technologies beats Ainos on 5 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Neonc Technologies (NASDAQ:NTHI) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

In the previous week, Neonc Technologies had 7 more articles in the media than Alvotech. MarketBeat recorded 7 mentions for Neonc Technologies and 0 mentions for Alvotech. Neonc Technologies' average media sentiment score of 0.22 beat Alvotech's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Alvotech Neutral
Neonc Technologies Neutral

Neonc Technologies has a consensus price target of $16.00, suggesting a potential upside of 199.63%. Given Neonc Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Neonc Technologies is more favorable than Alvotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alvotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Neonc TechnologiesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Neonc Technologies N/A N/A N/A

Summary

Neonc Technologies beats Alvotech on 5 of the 6 factors compared between the two stocks.

How does Neonc Technologies compare to Aravive?

Neonc Technologies (NASDAQ:NTHI) and Aravive (NASDAQ:ARAV) are both pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Neonc TechnologiesN/A N/A N/A
Aravive N/A N/A N/A

Neonc Technologies currently has a consensus target price of $16.00, suggesting a potential upside of 199.63%. Given Neonc Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe Neonc Technologies is more favorable than Aravive.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Aravive
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neonc TechnologiesN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Neonc Technologies had 7 more articles in the media than Aravive. MarketBeat recorded 7 mentions for Neonc Technologies and 0 mentions for Aravive. Neonc Technologies' average media sentiment score of 0.22 beat Aravive's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Neonc Technologies Neutral
Aravive Neutral

Summary

Neonc Technologies beats Aravive on 5 of the 7 factors compared between the two stocks.

How does Neonc Technologies compare to Atlantic Coastal Acquisition Corp. II?

Neonc Technologies (NASDAQ:NTHI) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neonc TechnologiesN/AN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

In the previous week, Neonc Technologies had 7 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 7 mentions for Neonc Technologies and 0 mentions for Atlantic Coastal Acquisition Corp. II. Neonc Technologies' average media sentiment score of 0.22 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Neonc Technologies Neutral
Atlantic Coastal Acquisition Corp. II Neutral

Company Net Margins Return on Equity Return on Assets
Neonc TechnologiesN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 199.63%. Given Neonc Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Neonc Technologies is more favorable than Atlantic Coastal Acquisition Corp. II.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Atlantic Coastal Acquisition Corp. II
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Neonc Technologies beats Atlantic Coastal Acquisition Corp. II on 5 of the 5 factors compared between the two stocks.

How does Neonc Technologies compare to Biofrontera?

Neonc Technologies (NASDAQ:NTHI) and Biofrontera (NASDAQ:BFRIW) are both pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

In the previous week, Neonc Technologies had 6 more articles in the media than Biofrontera. MarketBeat recorded 7 mentions for Neonc Technologies and 1 mentions for Biofrontera. Neonc Technologies' average media sentiment score of 0.22 beat Biofrontera's score of 0.00 indicating that Neonc Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Neonc Technologies
0 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Biofrontera
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Neonc Technologies presently has a consensus price target of $16.00, suggesting a potential upside of 199.63%. Given Neonc Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe Neonc Technologies is more favorable than Biofrontera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neonc Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Biofrontera
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neonc TechnologiesN/AN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Neonc TechnologiesN/A N/A N/A
Biofrontera N/A N/A N/A

Summary

Neonc Technologies beats Biofrontera on 5 of the 6 factors compared between the two stocks.

Get Neonc Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTHI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NTHI vs. The Competition

MetricNeonc TechnologiesPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$918.92M$4.25B$12.32B
Dividend YieldN/A4.84%5.93%5.28%
P/E RatioN/A1.4621.9625.66
Price / SalesN/A120.05125.30111.99
Price / CashN/A20.0755.6856.67
Price / BookN/A7.5934.857.14
Net IncomeN/A-$3.64M$112.32M$335.98M
7 Day PerformanceN/A1.93%2.55%3.56%
1 Month Performance11.72%76.78%3.54%2.54%
1 Year Performance-26.04%126.62%15.79%35.05%

Neonc Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTHI
Neonc Technologies
4.5765 of 5 stars
$5.34
flat
$16.00
+199.6%
-26.0%$0.00N/AN/A8
AIMDW
Ainos
N/A$0.08
+29.8%
N/A-71.2%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.18
-10.0%
N/A-89.5%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/A-77.3%$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:NTHI) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners